Prospective, Assessment of Vitamin D and Calcium Supplementation, Improvement of Nutritional Status and Preoperative Rehabilitation in Patients Before Knee Arthroplasty.
28 de fevereiro de 2020 atualizado por: Bartlomiej Szpyra, Jagiellonian University
Prospective randomized study of 150 patients qualified for knee arthroplasty between 2015 and 2017. Patients were randomized into 3 groups receiving vitamin D and calcium supplementation, increased protein supply and preoperative rehabilitation, respectively.
Following factors were analyzed: changes in vitamin D3, calcium, total protein, albumin and CRP levels during preparation for surgery, nutritional status on the Subjective Global Assessment (SGA) scale, osteoporosis risk assessment according to the Osteoporosis Risk SCORE, level of pain felt on the scale VAS and the number of analgesics used, the result of the Duke Activity Status Index, the result of the following scales: Cardiac Risk Index for Orthopedic Surgery (Lee), Knee injury and Osteoarthritis Outcome Score (KOOS), Fear Avoidance Beliefs Questionnaire (FABQ) about Physical Activity, The Quality of Life Scale (QOLS). Additionally, the occurrence of perioperative complications was analyzed (e.g. venous thrombosis and pulmonary embolism, wound or joint infection, excessive bleeding, loosening of the implant, bone fracture or fracture, pain).
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
150
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Malopolska
-
Kraków, Malopolska, Polônia, 31-559
- Bartlomiej Szpyra
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
Não mais velho que 85 anos (Filho, Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- with a disease lasting more than 5 years and without total limitation of physical fitness,
- reporting pain> 5 on the VAS scale (Visual Analogue Scale)
- general fitness according to the ASA (Amercican Society of Anestesiology) scale up to 3
Exclusion Criteria:
- patients with metabolic and systemic disorders with contraindications for calcium substitution, vitamin D3 and protein supply,
- intolerance of physical effort> 2, 5 MET (Metabolic Equivalent of Task)
- limitation of the degree overall efficiency> 3 in the ASA classification
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Intervention group 1
Protein supplementation BID, Vitamin D and calcium supplementation Vitamin D 2000 IU / d, calcium 1000mg/d, exercise 6 months
|
Protein supplementation BID, Vitamin D and calcium supplementation Vitamin D 2000 IU / d, calcium 1000mg/d, exercise 6 months
|
|
Comparador Ativo: Intervention group 2
Protein supplementation QD, Vitamin D and calcium supplementation Vitamin D 1000 IU / d, calcium 500mg/d, exercise 3 months
|
Protein supplementation QD, Vitamin D and calcium supplementation Vitamin D 1000 IU / d, calcium 500mg/d, exercise 3 months
|
|
Comparador de Placebo: Control group 0
no protein supplementation , no Vitamin D and calcium supplementation , no exercise
|
no protein supplementation , no Vitamin D and calcium supplementation , no exercise
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain control satisfaction assessed on the Visual Analogue Scale (VAS)
Prazo: 18 months
|
Visual Analogue Scale (VAS) is a measure determining the intensity of pain by means of a visual analogue scale.
Subject is marking the examined point on a line of 10 cm long, where the value 0 is assigned the total absence of pain, and 10 the strongest pain that can be imagined.
|
18 months
|
|
Vitamin D concentration in blood, based on laboratory analysis.
Prazo: 18 months
|
Concentration of vitamin D in blood is a laboratory parameter, measured in unit of ng/ml.
Levels below 20 ng/ml is a severe vitamin D deficiency condition that requires treatment.
The result in the range 20-30 ng/ml means that the vitamin level is not sufficient.
Values between 30-50 ng/ml are considered normal.
This is one of the basic laboratory parameters for assessing the body's bone mineral metabilism.
|
18 months
|
|
Efficiency of the knee joint assessed on The Knee Injury and Osteoarthritis Outcome Score (KOOS) scale.
Prazo: 18 months
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a questionnaire designed to assess short and long-term patient-relevant outcomes following knee injury.
The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.
Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures.
Scores between 0 and 100 represent the percentage of total possible score achieved.
|
18 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Calcium ionized concentration in blood, based on laboratory analysis.
Prazo: 18 months
|
Calcium ionized concentration in blood is a laboratory parameter, measured in unit of mmol/l.
The results below 1.16 mmol/l mean that the level is not sufficient, condition called hypocalcemia.
Values between 1.16-1.32
mmol/l are considered normal.
The results above 1.32 mmol/l mean hypercalcemia occurs.
This is one of the basic laboratory parameters for assessing the body's bone mineral metabilism.
|
18 months
|
|
Total protein concentration in blood, based on laboratory analysis.
Prazo: 18 months
|
Total protein concentration in blood is a laboratory parameter, measured in unit of g/l.
The results below 60 g/l mean that the level is not sufficient, condition called hypoproteinemia.
Values between 60-80 g/l are considered normal.
The results above 80 g/l mean hyperproteinemia occurs.
This is one of the basic laboratory parameters for assessing the body's nutritional status.
|
18 months
|
|
Albumin concentration in blood, based on laboratory analysis
Prazo: 18 months
|
Albumin concentration in blood is a laboratory parameter, measured in unit of mg/ml.
The results below 35 mg/l mean that the level is not sufficient, condition called hypoalbuminemia.
Values between 35-50 mg/ml are considered normal.
The results above 50mg/l mean hyperalbuminemia occurs.
This is one of the basic laboratory parameters for assessing the body's nutritional status.
|
18 months
|
|
C-reactive protein (CRP) concentration in blood, based on laboratory analysis
Prazo: 18 months
|
C-reactive protein concentration in blood is a laboratory parameter, measured in unit of mg/l.
The results below 5 mg/l are considered normal.
The results above 5mg/l mean infection, trauma, stress or other aggravating factor.
This is the major laboratory parameter for assessing homeostatic balance.
|
18 months
|
|
Efficacy of protein supplementation assessed on the Subjective Global Assessment (SGA) scale.
Prazo: 18 months
|
Subjective global assessment (SGA) is the gold standard for diagnosing malnutrition.
SGA is a simple bedside questionnaire method used to diagnose malnutrition and identify those who would benefit from nutrition care.
The assessment includes taking a history of recent intake, weight change, gastrointestinal symptoms and a clinical evaluation.
Results are on a scale from 1 to 7. Values 1 and 2 means high risk of malnutririon, from 3 do 5 medium risk, and from 6 do 7 mild risk.
|
18 months
|
|
Efficacy of vitamin D and calcium supplementation assessed on the Simple Calculated Osteoporosis Risk Estimation (SCORE) scale.
Prazo: 18 months
|
Simple Calculated Osteoporosis Risk Estimation (SCORE) scale is the questionnaire tool for diagnosing Osteoporosis risk.
It has been reported to appropriately identify person who should be referred for bone densitometry.
Results are on a scale from 0 to 50 points.
Points from 16 to 50 means high risk of osteoporosis , points from 7 to 15 moderate risk and from 0 do 6 low risk of osteoporosis.
|
18 months
|
|
Acceptability of physical activity based on Duke Activity Status Index (DASI) scale.
Prazo: 18 months
|
The Duke Activity Status Index is a self-administered questionnaire that measures a patient's functional capacity.
It can be used to get a rough estimate of a patient's peak oxygen uptake.
Results are on a scale from 0 to 57,95 points.
The higher the score, the more intense the acceptable physical activity.
|
18 months
|
|
Incidence of cardiovascular hazard based on Cardiac Risk Index for Orthopedic Surgery (Lee) scale.
Prazo: 18 months
|
Cardiac Risk Index for Orthopedic Surgery (Lee) is the questionnaire tool for diagnosing cardiovascular hazard in orthopedics patients.
Results are on a scale from 0 to 6 points.
Points from 3 to 6 means estimated risk of 4%, 2 points is 2,3% of risk, 1 point is 1,7% of risk and 0 points means less than 1 % of cardiovascular event.
|
18 months
|
|
Unwillingness of phisical activity due to pain based on Fear Avoidance Beliefs Questionnaire (FABQ) scale.
Prazo: 18 months
|
Fear Avoidance Beliefs Questionnaire (FABQ) scale is a questionnaire based on the Fear-Avoidance Model of Exaggerated Pain Perception, a model created in attempts to explain why some patients with acute painful conditions can recover while other patients develop chronic pain from such conditions.
The FABQ focuses specifically on how a patient's fear-avoidance beliefs about physical activity and work.
It consists of 16 questions scaled form 0 do 6, higher score indicates fear avoidance behaviors.
|
18 months
|
|
The Quality of Life based on The Quality of Life (QOLS) scale.
Prazo: 18 months
|
The Quality of Life (QOLS) scale is the most known scale measures factors like satisfaction, perceptions of control, involvement, commitment, and work-life balance, in terms of one's personal perception.
QOLS has 16 items, scaled form 1 do 7, higher score indicates superior appraisal of each aspect of life.
|
18 months
|
|
Incidence of Treatment-Emergent Adverse Events (AE) as assessed by frequency.
Prazo: 18 months
|
Incidence of Adverse Events (AE) was summed up and analyzed in each group. They were divided into 7 groups.
|
18 months
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de janeiro de 2015
Conclusão Primária (Real)
31 de dezembro de 2017
Conclusão do estudo (Real)
31 de dezembro de 2017
Datas de inscrição no estudo
Enviado pela primeira vez
27 de fevereiro de 2020
Enviado pela primeira vez que atendeu aos critérios de CQ
28 de fevereiro de 2020
Primeira postagem (Real)
2 de março de 2020
Atualizações de registro de estudo
Última Atualização Postada (Real)
2 de março de 2020
Última atualização enviada que atendeu aos critérios de controle de qualidade
28 de fevereiro de 2020
Última verificação
1 de fevereiro de 2020
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Processos Patológicos
- Complicações pós-operatórias
- Dor
- Manifestações Neurológicas
- Distúrbios Nutricionais
- Doenças articulares
- Doenças musculoesqueléticas
- Doenças Reumáticas
- Artrite
- Avitaminose
- Doenças de Deficiência
- Desnutrição
- Osteoartrite
- Dor, Pós-operatório
- Osteoartrite, Joelho
- Deficiência de Vitamina D
Outros números de identificação do estudo
- KBET/271/B/2014
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .